T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Danaher
DHR
|
+$764M |
| 3 |
Intuit
INTU
|
+$679M |
| 4 |
PTC
PTC
|
+$559M |
| 5 |
Avantor
AVTR
|
+$447M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$766M |
| 2 |
Spotify
SPOT
|
+$730M |
| 3 |
KKR & Co
KKR
|
+$587M |
| 4 |
Goldman Sachs
GS
|
+$531M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$515M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Repligen
RGEN
$9.42B
| $64.4M | 0.04% |
510,616
+84,102
| +20% | +$13.2M |
|
352
Asbury Automotive
ABG
$3.75B
| $64.1M | 0.04% |
281,302
-10,912
| -4% | -$2.48M |
|
353
Rexford Industrial Realty
REXR
$8.13B
| $64.1M | 0.04% |
1,437,450
-1,093,059
| -43% | -$49.2M |
|
354
Shake Shack
SHAK
$2.94B
| $64M | 0.04% |
711,459
+34,636
| +5% | +$3.38M |
|
355
Novanta
NOVT
$6.36B
| $63.8M | 0.04% |
391,334
-180,716
| -32% | -$29.3M |
|
356
Viper Energy
VNOM
$14.7B
| $63.4M | 0.04% |
1,690,099
+252,405
| +18% | +$9.6M |
|
357
Monro
MNRO
$365M
| $63.3M | 0.04% |
2,653,340
-1,872,730
| -41% | -$50M |
|
358
Mine Safety
MSA
$7.31B
| $63.2M | 0.04% |
336,880
+1,255
| +0.4% | +$233K |
|
359
Duolingo
DUOL
$6.38B
| $63M | 0.04% |
301,825
-42,712
| -12% | -$8.75M |
|
360
Red Rock Resorts
RRR
$3.67B
| $62.9M | 0.04% |
1,144,990
-153,734
| -12% | -$8.34M |
|
361
APi Group
APG
$18.7B
| $62.9M | 0.04% |
2,505,965
+330,680
| +15% | +$8.3M |
|
362
Alignment Healthcare
ALHC
$2.83B
| $62.8M | 0.04% |
8,033,241
-270,901
| -3% | -$1.77M |
|
363
Carpenter Technology
CRS
$26.8B
| $62.1M | 0.04% |
566,430
-125,078
| -18% | -$12M |
|
364
Installed Building Products
IBP
$6.52B
| $61.8M | 0.04% |
300,515
-7,548
| -2% | -$1.7M |
|
365
Healthcare Realty
HR
$6.61B
| $61.8M | 0.04% |
3,747,812
-146,927
| -4% | -$2.25M |
|
366
Group 1 Automotive
GPI
$3.13B
| $61.4M | 0.04% |
206,520
-18,333
| -8% | -$5.43M |
|
367
Crinetics Pharmaceuticals
CRNX
$8.97B
| $60.3M | 0.04% |
1,347,210
-1,307,519
| -49% | -$60.4M |
|
368
Lantheus
LNTH
$6.59B
| $60.2M | 0.04% |
749,658
-16,089
| -2% | -$1.18M |
|
369
On Holding
ONON
$10.3B
| $60.2M | 0.04% |
+1,550,480
| New | +$56.6M |
|
370
Webster Financial
WBS
$12.8B
| $59.9M | 0.04% |
1,373,465
-9,901
| -0.7% | -$441K |
|
371
Agilysys
AGYS
$3.06B
| $58.8M | 0.04% |
564,838
-70,351
| -11% | -$6.31M |
|
372
Nomad Foods
NOMD
$1.64B
| $57.7M | 0.04% |
3,502,627
-354,214
| -9% | -$6.38M |
|
373
Xenon Pharmaceuticals
XENE
$6.2B
| $56.1M | 0.04% |
1,439,903
+13,564
| +1% | +$542K |
|
374
Vishay Intertechnology
VSH
$5.27B
| $55.8M | 0.04% |
2,502,745
+188,312
| +8% | +$4.26M |
|
375
FIGS
FIGS
$2.44B
| $54.5M | 0.03% |
10,217,953
+86,092
| +0.8% | +$440K |
|
Similar funds
T. Rowe Price Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Investment Management held 668 positions worth $158B, down 3.1% from $163B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q2 2024 filing shows 48 new, 292 increased, 275 reduced and 48 closed positions. Its largest new stake was Broadcom: 5,594,890 shares worth $898M. The largest sale was CrowdStrike, an estimated $766M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- T. Rowe Price Investment Management's largest Q2 2024 buy was Broadcom: 5,594,890 shares worth $898M.
- T. Rowe Price Investment Management added most to Danaher in Q2 2024, an estimated $764M increase.
- T. Rowe Price Investment Management's biggest Q2 2024 reduction was CrowdStrike, cutting an estimated $766M.
- T. Rowe Price Investment Management fully exited CATALENT, INC. in Q2 2024, selling an estimated $231M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $158B portfolio in Q2 2024.
- T. Rowe Price Investment Management opened 48 new positions and closed 48 in Q2 2024.
- T. Rowe Price Investment Management's portfolio value fell 3.1% quarter-over-quarter to $158B.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.